You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for THEOPHYLLINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for THEOPHYLLINE

Average Pharmacy Cost for THEOPHYLLINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
THEOPHYLLINE ER 300 MG TABLET 23155-0741-01 0.68135 EACH 2024-12-18
THEOPHYLLINE ER 300 MG TABLET 00480-3310-01 0.68135 EACH 2024-12-18
THEOPHYLLINE ER 600 MG TABLET 68462-0356-01 1.11766 EACH 2024-12-18
THEOPHYLLINE 80 MG/15 ML SOLN 27808-0033-01 0.09449 ML 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for THEOPHYLLINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
THEOPHYLLINE 300MG TAB,SA AvKare, LLC 42291-0922-01 100 338.48 3.38480 EACH 2023-07-06 - 2028-06-14 FSS
THEOPHYLLINE,ANHYDROUS 80MG/15ML (SF) ELIXIR Golden State Medical Supply, Inc. 00121-0820-16 473ML 29.15 0.06163 ML 2023-06-15 - 2028-06-14 FSS
THEOPHYLLINE 300MG TAB,SA AvKare, LLC 42291-0922-01 100 321.56 3.21560 EACH 2023-08-17 - 2028-06-14 FSS
THEOPHYLLINE,ANHYDROUS 80MG/15ML (SF) ELIXIR Golden State Medical Supply, Inc. 00121-0820-16 473ML 31.14 0.06584 ML 2023-06-23 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

THEOPHYLLINE Market Analysis and Financial Projection

Theophylline Market Analysis and Price Projections

Market Overview

The global theophylline market is experiencing significant growth, driven primarily by the increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Here is a comprehensive analysis of the market trends, projections, and key factors influencing the growth of the theophylline market.

Market Size and Growth Projections

As of 2024, the global theophylline market size is estimated to be USD 451.5 million. This market is projected to expand at a compound annual growth rate (CAGR) of 6.50% from 2024 to 2031, reaching USD 701.62 million by 2031[1][4].

Geographical Trends

North America

North America currently dominates the theophylline market, holding more than 40% of the global revenue with a market size of USD 180.6 million in 2024. This region is expected to grow at a CAGR of 4.7% from 2024 to 2031, driven by a high prevalence of respiratory diseases and advanced healthcare infrastructure[1].

Europe

Europe holds around 30% of the global revenue, with a market size of USD 135.45 million in 2024. The region is anticipated to grow at a CAGR of 5.0% from 2024 to 2031[1].

Asia-Pacific

The Asia-Pacific region, with a market share of around 23% and a market size of USD 103.85 million in 2024, is expected to experience the highest growth rate with a CAGR of 8.5% from 2024 to 2031. This growth is attributed to rising respiratory diseases, an aging population, and increasing healthcare access[1].

Latin America and Middle East & Africa

Latin America and the Middle East & Africa hold smaller market shares, with 5% and 2% respectively, but are also expected to see growth, with CAGRs of 5.9% and 6.2% from 2024 to 2031[1].

Application and Product Segments

The theophylline market is segmented based on application and product types.

Application

The primary applications of theophylline include the treatment of asthma, insomnia, and other respiratory conditions. The rising incidence of asthma and COPD is a significant driver for the market[4].

Product

Theophylline is available in various forms such as injections, tablets, and capsules. Extended-release tablets are particularly popular due to their convenience and efficacy in managing chronic conditions[2][4].

Key Drivers and Trends

Rising Prevalence of Respiratory Diseases

The increasing incidence of respiratory diseases such as asthma and COPD is a major factor driving the demand for theophylline. Demographic factors like aging populations and environmental pollution are exacerbating this trend[1][4][5].

Advancements in Pharmaceutical Research

Continuous research and development in pharmaceuticals are leading to novel formulations and delivery systems, improving the safety and efficacy of theophylline-based treatments. This includes personalized medicine, which is creating lucrative opportunities for manufacturers[4][5].

Strategic Partnerships and Market Access

Strategic partnerships between pharmaceutical companies and healthcare providers are enhancing market reach and ensuring greater access to theophylline pharmaceuticals, further propelling market growth[4].

Competitive Landscape

The theophylline market is highly competitive, with several key players including Mitsubishi Tanabe Pharma, Nichi-Iko Pharmaceutical, Teva, Glenmark Pharmaceuticals Limited, and others. These companies are adopting various strategies such as product portfolio expansion, regional development, mergers, and acquisitions to strengthen their market positions[3][5].

Price Projections and Cost Analysis

The cost of theophylline varies based on the form and dosage.

Extended Release Tablets

For example, the cost for theophylline 300 mg oral tablet, extended release, is around $207 for a supply of 100 tablets. Prices can vary depending on the pharmacy and availability[2].

Oral Elixir and Solution

Theophylline oral elixir and solution also have varying prices, with the oral elixir costing from $104.49 for 473 milliliters and the oral solution costing from $45.26 for 473 milliliters[2].

Challenges and Opportunities

Challenges

Despite the growth, the market faces challenges such as stock shortages and pricing variability due to unknown variables. Additionally, the presence of substitutes and the threat of new entrants can impact market dynamics[2][4].

Opportunities

The increasing demand for cost-effective and convenient treatments for respiratory diseases presents significant opportunities for manufacturers. Innovations in personalized medicine and strategic partnerships can further enhance market growth[4][5].

Key Takeaways

  • The global theophylline market is projected to grow from USD 451.5 million in 2024 to USD 701.62 million by 2031.
  • North America dominates the market, but the Asia-Pacific region is expected to experience the highest growth rate.
  • Rising respiratory diseases, advancements in pharmaceutical research, and strategic partnerships are key drivers.
  • The market is highly competitive with several key players.
  • Prices vary based on the form and dosage of theophylline.

FAQs

1. What is the current market size of the global theophylline market?

The global theophylline market size is estimated to be USD 451.5 million in 2024[1].

2. What is the projected growth rate of the theophylline market from 2024 to 2031?

The theophylline market is expected to grow at a CAGR of 6.50% from 2024 to 2031[1].

3. Which region dominates the theophylline market?

North America currently dominates the theophylline market, holding more than 40% of the global revenue[1].

4. What are the primary applications of theophylline?

The primary applications of theophylline include the treatment of asthma, insomnia, and other respiratory conditions[4].

5. How much does a supply of 100 theophylline 300 mg extended-release tablets typically cost?

The cost for a supply of 100 theophylline 300 mg oral tablets, extended release, is around $207[2].

Cited Sources

  1. Cognitive Market Research: Theophylline Market Report 2024[1].
  2. Drugs.com: Theophylline Prices, Coupons, Copay Cards & Patient Assistance[2].
  3. Valuates Reports: Theophylline Sustained Release Tablets - Market[3].
  4. Market Research Intellect: Theophylline Market Size, Trends and Projections[4].
  5. Future Market Insights: Theophylline And Aminophylline Market Size, Demand & Trends[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.